# EURopean Trial In Atrial Fibrillation(AF) or Flutter (AFL) Patients Receiving Dronedarone for the maIntenance of Sinus Rhythm (EURIDIS)

> **NCT00259428** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 615 (actual)

## Conditions studied

- Atrial Fibrillation
- Atrial Flutter

## Interventions

- **DRUG:** Dronedarone (SR33589)
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00259428
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-11
- **Primary completion:** 2003-08
- **Final completion:** 2003-08
- **Target enrollment:** 615 (ACTUAL)
- **Last updated:** 2010-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00259428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00259428, "EURopean Trial In Atrial Fibrillation(AF) or Flutter (AFL) Patients Receiving Dronedarone for the maIntenance of Sinus Rhythm (EURIDIS)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00259428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*